INTELLIGENCE IN ACTION

HIMSS19 Highlights: Five Takeaways from Healthcare Leaders on Prescription Price Transparency

March 15, 2019

Judging by recent news headlines and my social media feed, this year’s HIMSS gathering seemed to be the most exciting and energized yet—not only because of the many emerging technologies under discussion and on display, but also the overall sense that the industry is making real progress, and positively impacting patient care in some very real ways. And the Surescripts Network Alliance™ led discussions throughout the show that demonstrated this impact through the lens of a very hot topic: prescription price transparency.

In true collaborative form, Dr. Steve Miller, Chief Clinical Officer of Cigna, and Dr. Troyen Brennan, Executive Vice President and Chief Medical Officer of CVS Health, joined Surescripts CEO Tom Skelton on stage for Views from the Top: Price Transparency in Prescription Drug Costs.




Check out the highlights video, which details:

  1. Why patients give up on their meds: Many patients choose to abandon treatment, due to delays that result from additional administrative work associated with their prescription, or out-of-pocket cost.


  2. The “horrible experience” that makes patients question their healthcare choices: Dr. Miller self-admittedly shares that doctors are too busy “making love to their keyboard” to truly connect with patients and provide high-quality care.


  3. How a little retail therapy might help: A more consumer-centric approach that mimics other positive online shopping experiences can empower patients and help inform their healthcare buying decisions.


  4. The real-time tool trio that’s changing the game: Three key technologies that, when combined, create a dramatically improved consumer experience—without unnecessary headaches at the pharmacy.


  5. And the mountain of money we can save: In addition to improved quality and safety, find out just how much money we can save every year by deploying these technologies at the point of care.

As our experts shared, the tools that will revolutionize patient-provider interaction are available today. Watch the full-length video to learn more. 

Related Articles

August 13, 2019

When Paperwork Comes Before Patients: Missing Key Information Complicates Specialty Prescribing

William J. Mayo, MD, (“Doctor Will”) said, “The best interest of the patient is the only interest to be considered, and in order that the sick may have the benefit of advancing knowledge, union of forces is necessary.”

Read more...
July 25, 2019

How Aurora Health Care Used Electronic Prior Authorization To Cut Clinic Staff Overtime By More Than Half

The reality of traditional prior authorization is this: While the prescriber, the PBM and the pharmacy team spend valuable time making phone calls, tracking down information and filling out forms, the patient waits. And waits. And waits. In other words, patients face delays in receiving their prescriptions, clinicians lose valuable time and the health system faces mounting overtime costs.

Read more...
July 22, 2019

The Onerous Specialty Prescribing Process Hurts Patients and Tires Doctors. What Can Be Done?

It really should be so simple—getting a patient on a specialty therapy. The doctor and patient have chosen the best therapy; the patient is in great need. But according to our recent survey of 500 prescribers, on average it can take nearly 8 days to start patients on specialty medications, which are used to treat challenging chronic conditions such as cancer, multiple sclerosis and rheumatoid arthritis. 

Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX